The ROE as of November 2024 (TTM) for Tenaya Therapeutics, Inc. (TNYA) is -80.97%

According to Tenaya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -80.97%. This represents a change of 297.46% compared to the average of -20.37% of the last 4 quarters.

Tenaya Therapeutics, Inc. (TNYA) Historical ROE (quarterly & annually)

How has TNYA ROE performed in the past?

The mean historical ROE of Tenaya Therapeutics, Inc. over the last ten years is -11.75%. The current -80.97% ROE has changed 588.84% with respect to the historical average. Over the past ten years (40 quarters), TNYA's ROE was at its highest in in the June 2021 quarter at 14.01%. The ROE was at its lowest in in the March 2020 quarter at -30.89%.

Tenaya Therapeutics, Inc. (TNYA) ROE by Quarter and Year

Discovering the peaks and valleys of Tenaya Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenaya Therapeutics, Inc. (TNYA) Average ROE

How has TNYA ROE performed in the past?

The current ROE of Tenaya Therapeutics, Inc. (TNYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tenaya Therapeutics, Inc. (TNYA) ROE vs. Peers

How is TNYA’s ROE compared to its peers?

Tenaya Therapeutics, Inc.’s ROE is greater than Bicycle Therapeutics plc (-27.35%), greater than IGM Biosciences, Inc. (-119.02%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Biomea Fusion, Inc. (-118.90%), greater than Akero Therapeutics, Inc. (-29.56%), greater than Homology Medicines, Inc. (-100.91%), greater than Gossamer Bio, Inc. (-117.33%), greater than Rani Therapeutics Holdings, Inc. (-300.92%), greater than Vincerx Pharma, Inc. (-276.65%), greater than Corvus Pharmaceuticals, Inc. (-53.99%), greater than ALX Oncology Holdings Inc. (-946.88%), greater than Eyenovia, Inc. (-615.55%), greater than Alpha Tau Medical Ltd. (-33.75%), greater than Ocular Therapeutix, Inc. (-62.56%), greater than Inozyme Pharma, Inc. (-68.93%),

Build a custom stock screener for Tenaya Therapeutics, Inc. (TNYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenaya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenaya Therapeutics, Inc. (TNYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenaya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.